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Abstract: The aim of this study was to
evaluate
the
clinical
efficacy
of
immunoscintigraphy with Tc-99m-labelled
antigranulocyte antibody in combination with
Tc-99m-methylene-diphosphonate (MDP)
bone scanning in diabetic foot infection. The
study group comprised 42 Type 2 diabetics
with foot infection. Pre- and postprandial
blood glucose level, HbA1c, urinary glucose,
microalbuminuria, total cholesterol, LDLcholesterol,
HDL-cholesterol,
and
bacteriological cultures were analyzed.
Investigation of transcutaneous oxygen
tension, vibration sensation, electromyography, and Doppler ankle/brachial systolic
blood pressure index was carried out.
Radiographs centered on the feet were
performed. All patients underwent bone
scintigraphy with 370 MBq Tc-99m-MDP
three hours after injection in 3 projections.
Radioimmune planar imunoscintigraphy was
performed with 740 MBq Technetium - 99m
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Introduction
Diabetic foot is a common pathology among diabetic
complications (1,2). Early diagnosis and effective
treatment of diabetic foot infection is essential for
prevention of amputation. Adequate diagnosis and
treatment of diabetic foot is based on a multidisciplinary
and multifactorial approach carried out by a diabetic foot
care team (3-8).
Isotopic procedures may be applied as part of the
complex diagnostic schedule of diabetic foot infection.
Technetium - 99m - methylene diphosphonate (Tc-99mMDP) bone scanning has high sensitivity, but low
specificity for the detection of osteomyelitis. The
neuroarthropathy, superimposition of cellulite, and
trauma increase non-specifically the uptake of bone
tracers. Therefore, several studies have applied labelled
leucocytes for the specific detection of diabetic foot
infection and osteomyelitis (9-12).

conjugated with monoclonal antigranulocyte
antibody BW 250/183 in the same three
projections.
Immunoscintigraphy
was
performed 4 and 24 hours after
administration of 740 MBq Tc-99m-MAB BW
250/183 in positive bone scan cases. Final
assessment of immunoscintigraphic images
based on parallel analysis of isotopic images
and final diagnosis revealed 21 true positive
cases, 16 true negative cases, 3 false positive
cases, and 2 false negative cases. The analysis
of diagnostic validity revealed a diagnostic
accuracy of 86 %. Immunoscintigraphy with
Tc-99m-labelled antigranulocyte antibody in
combination with Tc-99m-MDP bone
scanning is an efficient method for the early
detection of foot bone infection and the
precise diagnosis of osteomyelities in
diabetics.
Key Words: diabetic foot, infection,
immunoscintigraphy, bone scintigraphy

The aim of this study was to evaluate the clinical
efficacy of immunoscintigraphy with Tc-99m-labelled
antigranulocyte antibody in combination with Tc-99mMDP bone scanning in diabetic foot infection.

Materials and methods
The study design was that of a longitudinal
prospective study including in-patients admitted for
diagnosis and treatment in the Clinic of Endocrinology,
Medical University, Varna.
Subjects
The study group comprised 42 Type 2 diabetics with
possible foot infection. The study was approved by the
local ethics committee. Informed consent was obtained
from all patients.
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Methods
All patients were subjected to a clinical, biochemical
and X-ray examination. Degree of glycemic control and
available complications were assessed. Pre- and
postprandial blood glucose level, HbA1c, urinary glucose,
microalbuminuria, total cholesterol, triglycerides, LDLcholesterol, HDL-cholesterol, bacteriological cultures
were analyzed. Lipid profile was investigated by an
enzyme method (Boehringer), glucose level by a glucoseoxidase method, and HbA1c by immuno-assay (Abbott).
Investigation of transcutaneous oxygen tension, vibration
sensation, electromyography, and Doppler ankle/brachial
systolic blood pressure index was carried out.
Radiographs centered on the feet were performed.
Vibration sensation was measured by Rydel-Seiffer’s
tuning fork with a scale for quantitative assessment
(values below 4 being considered an indication of diabetic
neuropathy).
Isotopic imaging techniques.
All patients underwent bone scintigraphy with 370
MBq Tc-99m-MDP three hours after injection in 3
projections. The MDP index (affected area/normal bone
tissue) was calculated. Radioimmune planar imaging was
performed in the same three projections by
immunoscintigraphy with 740 MBq Technetium (Tc) 99m conjugated with monoclonal antigranulocyte
antibody (MAb) BW 250/183 (Behring Werke, Marburg
FRG/ Cis/France). Immunoscintigraphy was performed 4
and 24 hours after administration of 740 MBq Tc-99mMAB BW 250/183 in cases with positive bone scans.
Interpretation of the images. Bone scan and
immunoscintigraphic images were compared and defined
as positive or negative for osteomyelitis. Final diagnosis
was established by clinical follow-up, and radiographic
and bacteriological results. Immunoscintigraphy was
evaluated as true positive if osteomyelitis was confirmed
as the final diagnosis and as false positive if osteomyelitis
was not confirmed. Immunoscintigraphy was assessed as
true negative if there were no other data for
osteomyelitis and as false negative if osteomyelitis was
confirmed by clinical, radiographical and bacteriological
results.

Statistical methods. Statistical analysis included
estimation of criteria for diagnostic validity: sensitivity,
specificity and diagnostic accuracy.
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Results
The data concerning the patients’ main characteristics
are summarized in Table 1. Table 2 illustrates the
calculated MDP index of the investigated patients. Final
diagnosis was verified by bacteriological cultures from
surgical material or bone biopsy and a long-term followup. After 6 months’ follow-up, a retrospective analysis of
clinical, radiological, isotopic and bacteriological data for
osteomyelitis was carried out. Final assessment of
immunoscintigraphic images based on parallel analysis of
isotopic images and final diagnosis revealed 21 true
positive cases, 16 true negative cases, 3 false positive
cases and 2 false negative cases (Table 3).
Table 1.

Clinical characteristics of the investigated patients

Characteristics

units

result

mean age
BMI
duration of diabetes
male / female
preprandial blood glucose
postprandial blood glucose
HbA1c
serum cholesterol
triglycerides
HDL-cholesterol
LDL-cholesterol
vibration sensation
(values are given after the scale of
Rydel-Seifer’s tuning fork)
Doppler ankle-arm systolic
blood pressure index
Transcutaneous tissue oxygen tension

years
kg/m2
years

53.7±6.1
25.6±3.2
12.5±5.2
22/20
10.1±1.2
14.1±1.1
9.4±1.4
6.8±0.7
2.3±0.9
0.74±0.2
4.4 ±0.15

mmol/l
mmol/l
%
mmol/l
mmol/l
mmol/l
mmol/l

3± 1
0.7 ± 0.1
92± 1.5

%

Values are given as mean±SD.

Table 2.

MDP - index of the investigated patients.

MDP-index

11.15 – 1.25

1.25 -130

1.30-1.35 1.35<

Patients

22

12

6

Table 3.

2

Assessment of immunoscintigraphic images

true positive cases

21

true negative cases

16

false positive cases

3

false negative cases

2
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Osteomyelitis was confirmed in 21 cases (Figure 1a,
Figure 1b) on the basis of clinical, radiographical and
bacteriological criteria. In 16 cases osteomyelitis was not
confirmed; the final diagnosis was cellulitis (out of these
- 12 cases were infected neuropathic plantar ulcers with
superimposed cellulitis, and 4 cases were infected
neuroischaemic foot ulcers with cellulitis). Two false
negative results were found in cases with chronic
infection. Three false positive results were established in
patients with infected ulcer.
Characteristics of diagnostic validity were analyzed
(Table 4). The estimated parameters of diagnostic validity

Table 4.

Parameters of diagnostic validity of the method of
combined application of Tc-99m-MDP- bone scintigraphy
and antigranulocyte immunoscintigraphy in patients with
diabetic foot and osteomyelitis.

Sensitivity

91%

Specificity

85%

Diagnostic accuracy

86%

of the applied method for detection of osteomyelitis were
sensitivity 91%, specificity 85%, and diagnostic accuracy
86%. The separate assessment of MDP-bone scintigraphy
applied at the first stage before application of

MEDICAL UNIVERSITY - VARNA Siemens Medical Systems
Figure 1a.

A case of a patient with type 2 diabetes - an ulcer of the right heel and foot bone infection. Bone scintigraphy demonstrates intensive activity in the zone of the right calcaneus. The MDP index is 1.42.

MEDICAL UNIVERSITY - VARNA Siemens Medical Systems
Figure 1b.

Planar immunoscintigraphy with 740 MBq Technetium-99m conjugated with monoclonal antigranulocyte antibody demonstrates an
increased uptake of labelled granulocytes in an area congruent with the MDP scanning. Final diagnosis osteomyelitis was confirmed by
bacteriological cultures.
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immunoscitigraphy revealed a sensitivity of 72% and a
specificity of 51%.

Discussion
This study presents data concerning the application of
isotopic methods for the visualization and precise
localization of osteomyelitis in diabetic patients. Patients
with possible foot infection requiring precise diagnosis
and adequate treatment were investigated. Patients’
biochemical and instrumental characteristics (Table 1)
confirm the state of poor glycemic control (preprandial
blood glucose level above 7.8 mmol/l), the existence of
diabetic neuropathy (low vibration sensation), and
peripheral diabetic macroangiopathy (Doppler ankle-arm
systolic pressure index below 0.9). Poor glycemic control
and available chronic diabetic complications (neuropathy,
macroangiopathy) are the background and one of the
main pathogenic reasons for the present diabetic
ulcerations and osteomyelitis. The MDP index (Table 2) is
above normal (upper normal limit 1), which could be
attributed to impaired foot bone turnover in the
investigated diabetic patients.
Different imaging techniques are applied for the
diagnosis of diabetic foot pathology (13-15). The
obligatory screening method applied in our study was
MDP bone scintigraphy. When applied in patients with
diabetic foot it non-specifically reveals zones of impaired
bone turnover. Because of the coexistence of different
pathogenic mechanisms (diabetic osteoarthropathy,
inflammation and trauma) positive bone scans alone are
insufficient to distinguish bone tissue damage from
osteomyelitis (16,17). Our data revealed relatively low
specificity (51%) and sensitivity (72%) as parameters of
MDP scanning. It is only the specific binding of
antigranulocyte antibody during immunoscintigraphy that
can differentiate infection from other causes (18,19).
Therefore, planar immunoscintigraphy was applied at a
second stage in all cases when bone scanning was
positive. The addition of MAb to MDP scanning raised
both the sensitivity and specificity and determined high
final diagnostic accuracy (86%).
Planar immunoscintigraph serves as an effective
diagnostic tool for precise localization of infection.
Granulocytes do not accumulate normally in the bones of
the foot. Uninfected neuropathic bones and
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osteoarthropathy do not fix granulocytes. The increased
uptake of labelled granulocytes is specific for infection.
Immunoscintigraphy detects any inflammatory
accummulation of granulocytes, both in soft and bone
tissue. For this reason it is a good diagnostic tool for the
accurate diagnosis of both cellulitis and osteomyelitis
(17).
It is not always possible to verify inflammation in bone
marrow using the gold standard procedure of bone
biopsy. Because of its high diagnostic accuracy,
immunoscintigraphy can serve as an efficient non-invasive
procedure for the early detection of bone marrow
inflammation. On the basis of verified diagnosis, adequate
early treatment can be undertaken. This leads to a better
prognosis and the avoidance of further complications,
surgical treatment and amputations.
The analysis of diagnostic validity in the detection and
precise localization of foot infection by the applied
method of planar immunoscintigraphic imaging in
combination with bone technetium scintigraphy revealed
a diagnostic accuracy of 86%. Our data are similar to
those of other studies (19,20). The established data for
high diagnostic accuracy confirm that antigranulocyte
immunoscintigraphy with 99m-Tc-labelled monoclonal
antigranulocyte antibody is an efficient method for the
early diagnosis and adequate therapeutic decision in
diabetic foot infection. Isotopic procedures could be
helpful in cases of diabetic foot infection; they could be
considered an essential part of the diabetic foot infection
diagnostic schedule.
In conclusion, our data confirm that the application of
immunoscintigraphy
with
Tc-99m-labelled
antigranulocyte antibody in combination with Tc-99mMDP bone scanning is an efficient method for the
detection of foot bone infection and the precise diagnosis
of osteomyelitis in diabetics.
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